Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease

Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS. 2006;20(1):49-57.

Publication Type:

Journal Article

Authors:

Merchante, N.; Giron-Gonzalez, J.A.; Gonzalez-Serrano, M.; et, al

Source:

AIDS, Volume 20, Issue 1, p.49-57 (2006)

Keywords:

Adult, Antiretroviral Therapy,Highly Active, Cause of Death, CD4 Lymphocyte Count, Child, Chronic Disease, Cohort Studies, complications, Death, Disease, drug therapy, End Stage Liver Disease, epidemiology, Female, HAART, Hepatic Encephalopathy, hepatitis, Hepatitis C, hepatitis C virus, Hiv, HIV Infections, HIV Protease, HIV Protease Inhibitors, Hospitals, Humans, Immunosuppression, Liver, Liver Cirrhosis, Liver Transplantation, Male, methods, Mortality, Multicenter Studies, Patients, Probability, Prognosis, Prospective Studies, protease inhibitor, Protease Inhibitors, Research, Research Support, Spain, Survival, Survival Analysis, therapeutic use, Time, Viral Load

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/16327319

Export Citation:

RIS Format

Top